Latest News

  • AVI BioPharma — Investor and Analyst Breakfast Schedule September 8, 2008, PORTLAND, Ore.
  • AVI BioPharma to Host Analyst & Investor Breakfast Meeting September 8, 2008, PORTLAND, Ore.
  • AVI BioPharma Announces Approval to Conduct Systemic Trial for Duchenne Muscular Dystrophy and Second Quarter 2008 Financial Results August 11, 2008, PORTLAND, Ore.

News Archives

  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002

Subscribe to the AVI RSS Newsfeed

About AVI BioPharma

  • Home
  • Corporate Profile
  • Company Overview
  • Management
  • Annual Report
  • Strategic Alliances
  • Corporate Governance

Technology

  • NeuGene Antisense
  • ESPRIT Technology
  • Clinical Studies
  • Publications

Communication

  • News
  • Employment
  • Contact Us

©2008 AVI BioPharma | Disclaimer | Subscribe to our Feed